Approval · Notice of Compliance 20722 · 2018
ONIVYDE: Notice of Compliance 20722
Issued April 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20722
- Date
- April 10, 2018
- Company
- Shire Pharma Canada UlcToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONIVYDE | 02467135 | Cancelled Post Market |
Medicinal ingredients
- IRINOTECAN HYDROCHLORIDE 4.3 MG per ML